VANI Gunggung Aset Perusahaan Vivani Medical, Inc.

Vivani Medical, Inc. (VANI) aims to expand the use of its NanoPRISM subcutaneous systems for automated drug delivery, seeking to capture a niche in diabetes therapy. This price chart confirms the current asset status, which stands at 35.27. Despite the risk of competing with pharmaceutical behemoths, the company relies on unique patents, which protect it from pricing pressure when developing micro-implants.

vivani.com - Total Aset Perusahaan VANI (periode 28.04.2023 - 31.10.2026)

Rincian metrik keuangan lan pasar vivani.com (VANI)

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan bursa Vivani Medical|VANI - Bagan rega target

- data kapitalisasi pasar:

Kapitalisasi pasar VANI|VANI - Nilai Total Perusahaan

- data nilai buku modal saham:

Nilai Buku Saham Vivani Medical|VANI - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku vivani.com|VANI - Total Aset Perusahaan

- rincian utang lan likuiditas:

Rasio Total Utang marang Ekuitas Vivani Medical, Inc.|VANI - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Vivani Medical|VANI - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku VANI|VANI - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Vivani Medical|Koefisien jangkoan perantara vivani.com

- rincian asil keuangan lan kelipatan valuasi:

VANI - Penghasilan resik

Pambiji fundamental:Vivani Medical, Inc.

This metric reflects the total resource volume of Vivani Medical, Inc. (VANI), reconstructed via return on assets (ROA) to evaluate the efficiency of capital and debt utilization. By analyzing the total asset value, an investor determines the resilience of Vivani Medical, Inc. (VANI) to the binary risks associated with the development of implants for diabetics, where the scale of the resource base confirms the technological potential within the ultra-long-term therapy segment.

Pesaing utama